Used in cancer research to block angiogenesis, the process of new blood vessel formation that tumors rely on for growth and metastasis. By inhibiting Tie2 kinase, this compound disrupts signaling pathways involved in vascular stability and endothelial cell survival, potentially enhancing the effectiveness of other anticancer therapies. It is also explored in studies of pathological conditions involving abnormal blood vessel development, such as certain eye diseases and vascular tumors. Its application remains primarily in preclinical research and drug development settings.